Response to Ibrutinib of a Refractory IgA Lymphoplasmacytic Lymphoma Carrying the MYD88 L265P Gene Mutation. Mediterr J Hematol Infect Dis 2019, 11 (1), e2019057. https://doi.org/10.4084/mjhid.2019.057.